Lemaitre Vascular (LMAT) Net Equity Issued and Repurchased (2010 - 2023)

Lemaitre Vascular (LMAT) has 14 years of Net Equity Issued and Repurchased data on file, last reported at $1.1 million in Q4 2023.

• On a quarterly basis, Net Equity Issued and Repurchased fell 38.61% year-over-year to $1.1 million in Q4 2023; TTM through Dec 2023 was $3.9 million, a 12.26% increase from a year earlier, with the FY2024 full-year figure at $6.4 million, up 4.38% from the prior year.
• Net Equity Issued and Repurchased for Q4 2023 stood at $1.1 million, down from $1.8 million in the prior quarter.
• Over the last five years, Net Equity Issued and Repurchased for LMAT reached as high as $59.5 million in Q3 2021 and fell as low as $43000.0 in Q2 2020.
• Historically, Net Equity Issued and Repurchased has averaged $4.6 million across 5 years, with a median of $1.1 million in 2023.
• Across the five-year window, Net Equity Issued and Repurchased surged 5020.84% in 2021 and tumbled 98.31% in 2022, its largest moves.
• Year by year, Net Equity Issued and Repurchased stood at $1.7 million in 2019, then soared by 163.91% to $4.5 million in 2020, then slumped by 63.06% to $1.7 million in 2021, then increased by 6.69% to $1.8 million in 2022, then plunged by 38.61% to $1.1 million in 2023.
• Per Business Quant data, the three most recent Net Equity Issued and Repurchased figures were $1.1 million in Q4 2023, $1.8 million in Q4 2022, and $1.0 million in Q3 2022.